Publication Cover
Xenobiotica
the fate of foreign compounds in biological systems
Volume 15, 1985 - Issue 12
17
Views
4
CrossRef citations to date
0
Altmetric
Research Article

Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. I. Studies in the rat

, , , , , , , & show all
Pages 1069-1087 | Received 01 Dec 1984, Published online: 22 Sep 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

A. Assandri, G. Tarzia, E. Bellasio, R. Ciabatti, G. Tuan, P. Ferrari, L. Zerilli, M. Lanfranchi & G. Pelizzi. (1987) Metabolic oxidation of the pyrrole ring: structure and origin of some urinary metabolites of the anti-hypertensive pyrrolylpyridazinamine, mopidralazine.: III: Studies with the 13C-labelled drug. Xenobiotica 17:5, pages 559-573.
Read now
A. Assandri, A. Perazzi, E. Bellasio, R. Ciabatti, G. Tarzia, P. Ferrari, A. Ripamonti, G. Tuan & L. F. Zerilli. (1985) Metabolic pathways of the anti-hypertensive agent, N-(2,5-dimethyl-1H-pyrrol-1-yl)-6-(4-morpholinyl)-3-pyridazinamine hydrochloride. II: Studies in the dog. Xenobiotica 15:12, pages 1089-1102.
Read now

Articles from other publishers (2)

Jie Jack Li. 2020. Medicinal Chemistry for Practitioners. Medicinal Chemistry for Practitioners 305 379 .
Gottfried Heinisch & Hannelore Kopelent-Frank. 1992. 141 183 .

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.